Search Results

Showing results 51-60 of 60 for 'Medicine'


  • bubble-boy
    In Service to the World

    Weizmann science is truly ""in service to the world,"" helping a ""bubble boy"" in Germany, a farmer in Kenya, a childless family in Canada, and more: from medicines to ease MS symptoms to a way to produce the nutrient beta-carotene from algae to science therapy programs for kids, Weizmann research helps people – including scientists – to live their dreams.

    /news-media/video-gallery/in-service-to-the-world
  • reeve
    Christopher Reeve: A Memorial

    Actor and activist Christopher Reeve, who became a quadriplegic after a horse-riding accident, was a supporter of the Institute's research on stem cells and on treating spinal cord injuries. This brief, touching video memorial is a poignant excerpt from a talk he gave during a visit to campus, in which he calls the Institute ""a symbol of the best in research.""

    /news-media/video-gallery/christopher-reeve-a-memorial
  • 2015-11-acwis-enews-web-landingpage-thumb
    November is American Diabetes Month

    As we enter a time of year abundant with food-centric holidays, it's helpful to think about how we eat – and how much. And given the link between overeating, obesity, and diabetes, it's no coincidence that November is American Diabetes Month. Weizmann scientists are looking at the complexities of diabetes and developing novel treatments.

    /news-media/feature-stories/november-is-american-diabetes-month
  • Weizmann Institute of Science and Clalit Health Services Will Collaborate to Advance the Field of Personalized Medicine and Improve Health Care Services

    In order for personalized medicine to reach its potential, scientists and the medical industry must collaborate. Recently, thanks to the Nancy and Stephen Grand Israel National Center for Personalized Medicine, the first meeting of this kind took place as Institute scientists met with experts from Israel's largest health care organization.

    /news-media/other/weizmann-institute-of-science-and-clalit-health-services-will-collaborate-to-advance-the-field-of-personalized-medicine-and-improve-health-care-services
  • berta-strulovici-tn.jpg
    New Clues Help Doctors Cure Patients, Not Diseases

    Israel21c covers the Nancy and Stephen Grand Israel National Center of Personalized Medicine at the Weizmann Institute, including discussion with Dr. Berta Strulovici, the center’s founding director. The G-INCPM is already studying acute myeloid leukemia, soft-tissue sarcoma, and retinitis pigmentosa.

    /news-media/in-the-news/new-clues-help-doctors-cure-patients-not-diseases
  • wilchek-and-rothenberg-1985.jpg
  • e800_20171008T162109.jpg
    “My Intuition Says Teva Will Get Out of This”

    “My intuition tells me that Teva will extricate itself,” Professor Michael Sela, who, together with Ruth Arnon and Deborah Teitelbaum, developed Teva’s blockbuster multiple sclerosis treatment Copaxone at the Weizmann Institute, told “Globes” yesterday.

    /news-media/in-the-news/my-intuition-says-teva-will-get-out-of-this
  • healthy-aging.png
  • 1ada-thumbnail.jpg
    Bacteria Alert by Scientist

    The Israeli crystallographer, who shared the chemistry Nobel with Venkatraman Ramakrishnan and Thomas A. Steitz in 2009 for her work on ribosome, was delivering the 79th Foundation Day lecture on “Next Generation Environmental Friendly Antibiotics” at Bose Institute on Thursday. “Resistance to antibiotics is a real big problem to modern medicine. Multi-drug resistance has developed not because we use antibiotics, but because bacteria has evolved and uses mechanisms against other bacteria in their fight for resources,” Yonath said.

    /news-media/in-the-news/bacteria-alert-by-scientist